Search Results
Search for other papers by Yong Lin in
Google Scholar
PubMed
Search for other papers by Xiaofei Jiang in
Google Scholar
PubMed
Search for other papers by Ye Shen in
Google Scholar
PubMed
Search for other papers by Min Li in
Google Scholar
PubMed
Search for other papers by Huili Ma in
Google Scholar
PubMed
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
Search for other papers by Yuan Lu in
Google Scholar
PubMed
PMD18-T-β-actin constructs with 10 2 –10 8 copies/μl DNA. Immunohistochemistry Immunohistochemical staining was performed on tissue sections to examine molecular markers of pituitary adenomas and protein expression of PIK3CA and Ki-67. Five
Search for other papers by M Xing in
Google Scholar
PubMed
mutation with additional sensitive and specific molecular markers will likely be the next step in increasing the FNAB diagnostic sensitivity. This approach was tested recently by combined use of BRAF mutation with RET/PTC ( Salvatore et al. 2004 ), a
Institute of Biomedicine, Departments of Pathology, Otorhinolaryngology, Developmental Biology, University of Helsinki, Biomedicum, Haartmaninkatu 8, PL 63, Helsinki 00014 HY, Finland
Search for other papers by V Häyry in
Google Scholar
PubMed
Search for other papers by K Salmenkivi in
Google Scholar
PubMed
Search for other papers by J Arola in
Google Scholar
PubMed
Search for other papers by P Heikkilä in
Google Scholar
PubMed
Search for other papers by C Haglund in
Google Scholar
PubMed
Institute of Biomedicine, Departments of Pathology, Otorhinolaryngology, Developmental Biology, University of Helsinki, Biomedicum, Haartmaninkatu 8, PL 63, Helsinki 00014 HY, Finland
Search for other papers by H Sariola in
Google Scholar
PubMed
histopathological material (Fisher's exact test P =0.006). Discussion Several histochemical and molecular markers (MIB-1, Cd34, VEGF, hTERT; p53, bcl-2 and c-erbB-2) have been investigated to identify the metastatic subgroup of phaeochromocytoma ( de Krijger et al
Rotterdam Adrenal Center, Department of Internal Medicine, Department of Pathology, Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Search for other papers by S G Creemers in
Google Scholar
PubMed
Rotterdam Adrenal Center, Department of Internal Medicine, Department of Pathology, Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Search for other papers by L J Hofland in
Google Scholar
PubMed
Rotterdam Adrenal Center, Department of Internal Medicine, Department of Pathology, Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Search for other papers by E Korpershoek in
Google Scholar
PubMed
Rotterdam Adrenal Center, Department of Internal Medicine, Department of Pathology, Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Search for other papers by G J H Franssen in
Google Scholar
PubMed
Rotterdam Adrenal Center, Department of Internal Medicine, Department of Pathology, Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Search for other papers by F J van Kemenade in
Google Scholar
PubMed
Rotterdam Adrenal Center, Department of Internal Medicine, Department of Pathology, Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Search for other papers by W W de Herder in
Google Scholar
PubMed
Rotterdam Adrenal Center, Department of Internal Medicine, Department of Pathology, Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Search for other papers by R A Feelders in
Google Scholar
PubMed
analyzed the discriminative value of the molecular markers were included in this overview. Total sensitivity and specificity represents a weighted mean Study ACC ( n ) ACA ( n ) Sens (%) Spec (%) Cutoff Reference diagnosis Comments IGF2 Gicquel et al
Search for other papers by Athanasios Bikas in
Google Scholar
PubMed
Search for other papers by Kirk Jensen in
Google Scholar
PubMed
Search for other papers by Aneeta Patel in
Google Scholar
PubMed
Search for other papers by John Costello Jr in
Google Scholar
PubMed
Search for other papers by Dennis McDaniel in
Google Scholar
PubMed
Search for other papers by Joanna Klubo-Gwiezdzinska in
Google Scholar
PubMed
Search for other papers by Olexander Larin in
Google Scholar
PubMed
Search for other papers by Victoria Hoperia in
Google Scholar
PubMed
Search for other papers by Kenneth D Burman in
Google Scholar
PubMed
Search for other papers by Lisa Boyle in
Google Scholar
PubMed
Search for other papers by Leonard Wartofsky in
Google Scholar
PubMed
Search for other papers by Vasyl Vasko in
Google Scholar
PubMed
was associated with overexpression of BiP in cells cultured in low-, but not in high-glucose medium ( Fig. 2 C). Expression of a molecular marker of oncosis (perforin) was also induced in thyroid cancer cells treated by metformin ( Fig. 2 C). Confocal
Search for other papers by G Galli in
Google Scholar
PubMed
Search for other papers by R Zonefrati in
Google Scholar
PubMed
Search for other papers by A Gozzini in
Google Scholar
PubMed
Search for other papers by C Mavilia in
Google Scholar
PubMed
Search for other papers by V Martineti in
Google Scholar
PubMed
Search for other papers by I Tognarini in
Google Scholar
PubMed
Search for other papers by G Nesi in
Google Scholar
PubMed
Search for other papers by T Marcucci in
Google Scholar
PubMed
Search for other papers by F Tonelli in
Google Scholar
PubMed
Search for other papers by M Tommasi in
Google Scholar
PubMed
Search for other papers by C Casini Raggi in
Google Scholar
PubMed
Search for other papers by P Pinzani in
Google Scholar
PubMed
Search for other papers by M L Brandi in
Google Scholar
PubMed
in culture. The rarity of somatostatinoma cell cultures makes the SS-C cell line a unique model for evaluation of both molecular marker expression and in vitro effects of molecules active on expressed targets. Here we provide evidence for control of
Search for other papers by G Bidaux in
Google Scholar
PubMed
Search for other papers by M Roudbaraki in
Google Scholar
PubMed
Search for other papers by C Merle in
Google Scholar
PubMed
Search for other papers by A Crépin in
Google Scholar
PubMed
Search for other papers by P Delcourt in
Google Scholar
PubMed
Search for other papers by C Slomianny in
Google Scholar
PubMed
Search for other papers by S Thebault in
Google Scholar
PubMed
Search for other papers by J-L Bonnal in
Google Scholar
PubMed
Search for other papers by M Benahmed in
Google Scholar
PubMed
Search for other papers by F Cabon in
Google Scholar
PubMed
Search for other papers by B Mauroy in
Google Scholar
PubMed
Search for other papers by N Prevarskaya in
Google Scholar
PubMed
prostate cancer. It is therefore essential to understand what drives the progression to androgen-independence and identify the molecular markers for both the early androgen-dependent and the advanced androgen-independent prostate cancer stages. It
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Stefano Caramuta in
Google Scholar
PubMed
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Linkiat Lee in
Google Scholar
PubMed
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Deniz M Özata in
Google Scholar
PubMed
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Pinar Akçakaya in
Google Scholar
PubMed
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Hong Xie in
Google Scholar
PubMed
Search for other papers by Anders Höög in
Google Scholar
PubMed
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Jan Zedenius in
Google Scholar
PubMed
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Martin Bäckdahl in
Google Scholar
PubMed
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Catharina Larsson in
Google Scholar
PubMed
Departments of Oncology-Pathology, Molecular Medicine and Surgery, Cancer Center Karolinska (CCK), Department of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Weng-Onn Lui in
Google Scholar
PubMed
adrenocortical tumor diagnostics, the identification of additional molecular markers with diagnostic and prognostic potential for clinical management of ACC is needed. Previous reports identified over-expression of IGF2, loss-of-heterozygosity at 11p15 and 17p13
Search for other papers by Brian Hung-Hin Lang in
Google Scholar
PubMed
Department of Surgery, Department of Surgery, School of Public Health, Department of Pathology, Cancer Research Institute, The University of Hong Kong, Hong Kong SAR, China
Search for other papers by Young Jun Chai in
Google Scholar
PubMed
Search for other papers by Benjamin J Cowling in
Google Scholar
PubMed
Search for other papers by Hye Sook Min in
Google Scholar
PubMed
Department of Surgery, Department of Surgery, School of Public Health, Department of Pathology, Cancer Research Institute, The University of Hong Kong, Hong Kong SAR, China
Search for other papers by Kyu Eun Lee in
Google Scholar
PubMed
Department of Surgery, Department of Surgery, School of Public Health, Department of Pathology, Cancer Research Institute, The University of Hong Kong, Hong Kong SAR, China
Search for other papers by Yeo-Kyu Youn in
Google Scholar
PubMed
, Zhao et al . 2013 ). In recent years, a T1799A point mutation in the v-raf murine sarcoma viral oncogene homolog B1 ( BRAF ) resulting in a valine-to-glutamic acid switch at codon 600 ( BRAF V600E ) has emerged as a molecular marker for aggressive
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Search for other papers by Mark Kidd in
Google Scholar
PubMed
Search for other papers by Leah Meuter in
Google Scholar
PubMed
Search for other papers by Irvin M Modlin in
Google Scholar
PubMed
therapies including surgery on the management of PPGLs. This study also indicates that PHEOs/PGLs may effectively secrete molecular markers that can be detected in the blood. There have been only a few other studies that have evaluated circulating levels